These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36275723)

  • 21. Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome.
    Gehlhar K; Schlaak M; Becker W; Bufe A
    Clin Exp Allergy; 1999 Apr; 29(4):497-506. PubMed ID: 10202364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation.
    Vrtala S; Ball T; Spitzauer S; Pandjaitan B; Suphioglu C; Knox B; Sperr WR; Valent P; Kraft D; Valenta R
    J Immunol; 1998 Jun; 160(12):6137-44. PubMed ID: 9637531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses.
    Eckl-Dorna J; Villazala-Merino S; Linhart B; Karaulov AV; Zhernov Y; Khaitov M; Niederberger-Leppin V; Valenta R
    Front Immunol; 2018; 9():3131. PubMed ID: 30705676
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Aglas L; Bethanis A; Chrusciel P; Stolz F; Gruen M; Jaakkola UM; Jongejan L; Yatkin E; Van Ree R
    Front Immunol; 2020; 11():2118. PubMed ID: 33013894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allergen-induced cytokine secretion in relation to atopic symptoms and immunoglobulin E and immunoglobulin G subclass antibody responses.
    Jenmalm MC; Björkstén B; Macaubas C; Holt BJ; Smallacombe TB; Holt PG
    Pediatr Allergy Immunol; 1999 Aug; 10(3):168-77. PubMed ID: 10565557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Functional IgE-Blocking Factor Induced by Allergen-Specific Immunotherapy Correlates with IgG4 Antibodies and a Decrease of Symptoms in House Dust Mite-Allergic Children.
    Zhao D; Lai X; Tian M; Jiang Y; Zheng Y; Gjesing B; Zhong N; Spangfort MD
    Int Arch Allergy Immunol; 2016; 169(2):113-20. PubMed ID: 27049773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy.
    Ball T; Sperr WR; Valent P; Lidholm J; Spitzauer S; Ebner C; Kraft D; Valenta R
    Eur J Immunol; 1999 Jun; 29(6):2026-36. PubMed ID: 10382766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass.
    Hussain R; Poindexter RW; Ottesen EA
    J Immunol; 1992 May; 148(9):2731-7. PubMed ID: 1573266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy.
    Sánchez Acosta G; Kinaciyan T; Kitzmüller C; Möbs C; Pfützner W; Bohle B
    J Allergy Clin Immunol; 2020 Oct; 146(4):894-900.e2. PubMed ID: 32259540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the role of antibody affinity and avidity in the IgE-mediated allergic response.
    Bachmann MF; Krenger PS; Mohsen MO; Kramer MF; Starchenka S; Whitehead P; Vogel M; Heath MD
    Allergy; 2024 Aug; ():. PubMed ID: 39189064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and immunotherapy of mould allergy. VII. IgG subclass response and relation to the clinical efficacy of immunotherapy with Cladosporium.
    Malling HJ; Djurup R
    Allergy; 1988 Jan; 43(1):60-70. PubMed ID: 3344936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG
    Eckl-Dorna J; Weber M; Stanek V; Linhart B; Ristl R; Waltl EE; Villazala-Merino S; Hummel A; Focke-Tejkl M; Froeschel R; Neubauer A; Henning R; Perkmann T; Valenta R; Niederberger V
    EBioMedicine; 2019 Dec; 50():421-432. PubMed ID: 31786130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allergen-Specific IgA Antibodies Block IgE-Mediated Activation of Mast Cells and Basophils.
    El Ansari YS; Kanagaratham C; Burton OT; Santos JV; Hollister BA; Lewis OL; Renz H; Oettgen HC
    Front Immunol; 2022; 13():881655. PubMed ID: 35865546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of IgG
    Heeringa JJ; McKenzie CI; Varese N; Hew M; Bakx ATCM; Aui PM; Rolland JM; O'Hehir RE; van Zelm MC
    Allergy; 2020 May; 75(5):1121-1132. PubMed ID: 31587307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in titres of IgE, IgG4 and other IgG subclass anti-Der p 2 antibodies in allergic and non-allergic patients measured with recombinant allergen.
    Tame A; Sakiyama Y; Kobayashi I; Terai I; Kobayashi K
    Clin Exp Allergy; 1996 Jan; 26(1):43-9. PubMed ID: 8789542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of allergen-specific IgE, IgG and IgA in allergic disease.
    Shamji MH; Valenta R; Jardetzky T; Verhasselt V; Durham SR; Würtzen PA; van Neerven RJJ
    Allergy; 2021 Dec; 76(12):3627-3641. PubMed ID: 33999439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical significance of allergen-specific IgG4 in allergic diseases.
    Qin L; Tang LF; Cheng L; Wang HY
    Front Immunol; 2022; 13():1032909. PubMed ID: 36389804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An unexpected protective role of low-affinity allergen-specific IgG through the inhibitory receptor FcγRIIb.
    Zha L; Leoratti FMS; He L; Mohsen MO; Cragg M; Storni F; Vogel M; Bachmann MF
    J Allergy Clin Immunol; 2018 Nov; 142(5):1529-1536.e6. PubMed ID: 29391255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained effect of grass pollen subcutaneous immunotherapy on suppression of allergen-specific basophil response; a real-life, nonrandomized controlled study.
    Zidarn M; Košnik M; Šilar M; Bajrović N; Korošec P
    Allergy; 2015 May; 70(5):547-55. PubMed ID: 25627309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.